Brazil’s health regulator, Anvisa, has made home delivery of regulated medicines permanent. Initially, this policy was a temporary pandemic measure.
However, Anvisa adjusted the maximum amount allowed per prescription. The higher pandemic-era limits are no longer valid.
For example, the old rules permitted delivery of up to 18 vials for a six-month supply. The new limit is five vials or enough for two months.
Pharmacies have certain rules for home delivery. They must:
- Obtain the prescription before making the delivery.
- Verify details like drug type, quantity, and expiration date.
- Keep the original prescription on file.
- Maintain a record of customer information.
- Collect required signatures when handing over the meds.
Both private and public pharmacies can use this service. Government programs are also authorized to deliver.
To sum up, Anvisa has made this service permanent while changing some rules. The new regulation balances safety and convenience.
Before, the rules were more lenient due to the health crisis. Yet, the permanent rule offers more strict controls.
This reflects Anvisa’s ongoing concern for public health. The new system aims to make long-term treatment more manageable.
This marks a shift in healthcare logistics in Brazil. It also aligns with global trends towards more convenient healthcare solutions.
Background
The concept of home delivery for medicines isn’t new globally but is significant for Brazil. Previously, stricter rules were in place to curb misuse.
The pandemic, however, forced a reevaluation. It showed the need for easier access to medication. Anvisa’s new rule is in line with this changed perspective.
This decision also benefits pharmacies. They can expand their service offerings, improving customer relations.
Yet, they also face the challenge of ensuring strict compliance. Authorities will likely increase scrutiny to prevent abuse of the system.
Anvisa’s new policy marks a milestone in Brazil’s healthcare evolution.